Wintac Ltd.
| BSE: 524758 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE812C01016 |
| BSE 00:00 | 17 Dec | Wintac Ltd |
| NSE 05:30 | 01 Jan | Wintac Ltd |
| OPEN | 345.00 |
| PREVIOUS CLOSE | 341.60 |
| VOLUME | 4199 |
| 52-Week high | 345.00 |
| 52-Week low | 0.00 |
| P/E | 194.09 |
| Mkt Cap.(Rs cr) | 342 |
| Buy Price | 341.60 |
| Buy Qty | 10000.00 |
| Sell Price | 343.75 |
| Sell Qty | 83.00 |
Wintac Ltd. (WINTAC) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 920.00 | 0.07 | 966.90 | 733.95 | 220735.59 |
| Divi's Lab. | 3947.80 | 0.05 | 5425.00 | 3365.10 | 104794.35 |
| Cipla | 1038.40 | 0.02 | 1083.15 | 850.00 | 83798.88 |
| Dr Reddy's Labs | 4257.15 | 0.35 | 5078.80 | 3655.00 | 70856.01 |
| Apollo Hospitals | 4434.25 | -1.88 | 5930.70 | 3365.90 | 63755.65 |
| Torrent Pharma. | 1535.25 | -0.37 | 1652.23 | 1242.50 | 51959.00 |
| Piramal Enterp. | 1906.25 | 4.70 | 3013.00 | 1561.00 | 45492.66 |
| Abbott India | 18941.95 | -3.40 | 23902.30 | 15525.00 | 40251.64 |
| Zydus Lifesci. | 381.75 | 4.69 | 577.35 | 319.40 | 39079.75 |
| Gland Pharma | 2347.65 | 1.75 | 4350.00 | 2180.10 | 38665.79 |
| Biocon | 315.75 | 0.81 | 410.50 | 305.00 | 37908.94 |
| Max Healthcare | 371.75 | 0.04 | 472.60 | 291.70 | 36046.00 |
| Alkem Lab | 2974.40 | 0.57 | 4067.70 | 2835.00 | 35558.95 |
| Aurobindo Pharma | 575.45 | 1.98 | 887.90 | 503.40 | 33715.62 |
| Lupin | 689.90 | 3.02 | 1090.60 | 583.05 | 31366.30 |
| Laurus Labs | 565.05 | 1.14 | 723.55 | 433.20 | 30362.96 |
| Ipca Labs. | 1015.50 | 2.38 | 1383.55 | 831.40 | 25763.24 |
| Glaxosmi. Pharma | 1442.30 | -0.19 | 1917.00 | 1372.80 | 24434.00 |
| Syngene Intl. | 581.85 | 0.67 | 686.00 | 508.10 | 23357.20 |
| Fortis Health. | 270.65 | 1.16 | 313.80 | 219.80 | 20432.99 |
Quick Links for Wintac:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
